AtheroGenics (AGIX) April option implied volatility Elevated into Trial Data

December 1, 2006 8:05 AM EST Send to a Friend
AtheroGenics (Nasdaq: AGIX) : AGIX focuses on the discovery, development and commercialization of novel drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login